LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients
Clinical trial NCT04391595 · COMPLETED
Trial details
- NCT number
- NCT04391595
- Sponsor
- Nader Sanai
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-11
- Primary completion
- 2023-07-27
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.